Drug intelligence / Profile preview

technetium (99mTc) nanocolloid

Development stage
Unknown
Lead developer
Sorin
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Subcutaneous
01

Overview

technetium (99mTc) nanocolloid is a diagnostic radiopharmaceutical consisting of colloidal human serum albumin (HSA) nanoparticles labeled with the metastable radioisotope technetium-99m (99mTc). It is primarily used as an imaging agent in nuclear medicine for lymphoscintigraphy, sentinel lymph node (SLN) mapping (particularly in breast cancer, melanoma, and other solid tumors), bone marrow scintigraphy, and the localization of inflammatory lesions. Following subcutaneous or interstitial injection, the nanocolloid particles (typically less than 80 nm in diameter) migrate through the lymphatic capillaries and are passively trapped by macrophages within the regional lymph nodes, allowing for precise visualization of lymphatic drainage and sentinel nodes via single-photon emission computed tomography (SPECT) or planar gamma imaging. When administered intravenously, the particles are rapidly cleared from the bloodstream by the reticuloendothelial system, accumulating in the liver, spleen, and bone marrow.

Brand names
NanoalbumonNanocollNanoscanNanotopSentiscintSolco Nanocoll
Other names
99mTc-albumin nanocolloid99mTc-nanocolloid99mTc-nanocolloidal albumintechnetium (99mTc) albumin nanocolloidtechnetium Tc 99m albumin nanocolloidtechnetium Tc-99m nanocolloidtechnetium-99 nanocolloidtechnetium99 nanocolloidtechnetium 99 nanocolloidtechnetium-99m albumin nanocolloidtechnetium99m albumin nanocolloidtechnetium 99m albumin nanocolloidtechnetium-99m nanocolloidtechnetium99m nanocolloidtechnetium 99m nanocolloid

Beyond the preview

Go deeper on technetium (99mTc) nanocolloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium (99mTc) nanocolloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call